Age (mean ± SD) |
50±18 |
49±17 |
53±20 |
0.307 |
Gender (Male:Female) |
50:15 |
39:12 |
11:3 |
0.870 |
Hypertension |
23 (35.4%) |
16 (31.4%) |
7(50%) |
0.200 |
Etiology of VT (ICMP:NICMP) |
30:35 |
22:29 |
8:6 |
0.356 |
Diabetes Mellitus |
12(18.5%) |
8 (15.7%) |
4(28.6%) |
0.291 |
Hyperlipidemia |
15 (23.1%) |
10 (19.6%) |
5(35.7%) |
0.209 |
Atrial Fibrillation |
7 (10.8%) |
5 (9.8%) |
2(14.3%) |
0.634 |
LVEF |
0.28±0.13 |
0.29±0.13 |
0.24±0.12 |
0.136 |
NYHA status prior to CSD
I
II
III
IV
|
3 (4.6%)
20 (30.8%)
35 (53.8%)
7 (10.8%)
|
5 (9.8%)
14(27.5%)
29(56.9%)
3(5.9%)
|
1 (7.1%)
0 (0%)
6 (42.9%)
7(50%)
|
0.001
|
Devices
implanted prior to CSD
No AICD
AICD
CRT-D
|
8(12.3%)
51(78.5%)
6 (9.2%)
|
7(13.7%)
40(78.4%)
4(7.8%)
|
1(7.1%)
11(78.6%)
2(14.3%)
|
0.356
|
Morphologies of VT
Monomorphic
Pleomorphic
Polymorphic
|
19(29.2%)
38 (58.5%)
8 (12.3%)
|
16(31.4%)
28(54.9%)
7(13.7%)
|
3(21.4%)
10(71.4%)
1(7.1%)
|
0.305
|
Radiofrequency ablation attempted prior to CSD |
14 (21.5%) |
11(21.6%) |
4 (28.6%) |
0.585 |
Medications
Amiodarone
B Blockers
|
55(83.3%)
41(62.1%)
|
44 (86.3%)
33 (64.7%)
|
11(78.6%)
2(21.4%)
|
0.483
0.606
|
Type of CSD
Unilateral (left)
Bilateral
|
5 (7.7%)
60 (92.3%)
|
4(7.8%)
47(92.2%)
|
1(7.1%)
13(92.9%)
|
0.931
|